## EG: Everest Group, Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.0% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($318.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Everest Group (EG) Valuation Check As New Insurance Leaders Step In And Q4 Earnings Near**
- Source: Simply Wall Street | 20260107T092228 | Somewhat-Bullish | Relevance: 100%
- Everest Group (NYSE:EG) is under scrutiny after recent leadership changes in its Global Wholesale Specialty Insurance division and ahead of its Q4 2025 earnings. Despite an 8.9% narrative undervaluation to US$364.73, the market's current P/E of 25.5x suggests the stock is richly priced compared to the US Insurance industry average of 13x, indicating significant embedded optimism for future growth. Investors are encouraged to assess whether the projected earnings growth can justify these high multiples.

**2. Everest Group (EG) Valuation Check As New Insurance Leaders Step In And Q4 Earnings Near**
- Source: Simply Wall Street | 20260106T234000 | Neutral | Relevance: 100%
- Everest Group (NYSE:EG) is under scrutiny as new leaders join its Global Wholesale Specialty Insurance division and Q4 2025 earnings approach. Despite a recent share price pullback, analysts see the stock as undervalued with a consensus price target of $393.429, though the market's current P/E ratio indicates a level of optimism. Investors are evaluating whether the company's future growth can justify its current valuation given potential risks like rising catastrophe losses.

**3. Everest Group to Hold Fourth Quarter 2025 Earnings Conference Call on Thursday, February 5, 2026**
- Source: Business Wire | 20260106T212226 | Neutral | Relevance: 100%
- Everest Group, Ltd. (NYSE: EG) will hold its fourth quarter 2025 earnings conference call on Thursday, February 5, 2026, at 8:00 AM Eastern Time. Financial results will be released on February 4, 2026, after the NYSE market close and will be available on their investor relations website. The call can be accessed via a live webcast, with replay also available, after completing a registration form.

**4. Everest Group to Hold Fourth Quarter 2025 Earnings Conference Call on Thursday, February 5, 2026**
- Source: FinancialContent | 20260106T161500 | Neutral | Relevance: 100%
- Everest Group, Ltd. (NYSE: EG) announced it will host its fourth quarter 2025 earnings conference call on Thursday, February 5, 2026, at 8:00 am Eastern Time. The company will release its financial results on February 4, 2026, after market close, with details and a webcast available on its investor relations website. Everest is a global underwriting leader in property, casualty, and specialty reinsurance and insurance solutions.

**5. Here's What to Expect From Everest Groupâ€™s Next Earnings Report**
- Source: Palmetto Grain Brokerage | 20260105T120803 | Neutral | Relevance: 100%
- Everest Group, Ltd. (EG) is set to release its Q4 fiscal 2025 earnings on Monday, February 2nd, with analysts projecting a significant rise in diluted EPS. Despite a recent stock decline following weaker Q3 results, the company's long-term outlook is positive, with analysts forecasting strong EPS growth for fiscal 2025 and 2026. Wall Street maintains a "Moderate Buy" rating, expecting an upside for the stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-06 | Keefe, Bruyette | $430 | $400 | +8% |
| 2025-12-16 | Mizuho | $359 | $0 | 0% |
| 2025-12-15 | TD Cowen | $365 | $400 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-06 | Keefe, Bruyette | main | Outperform |
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-15 | TD Cowen | main | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (-1.0%)
- Blackrock Inc.: 8.1% (-2.9%)
- AQR Capital Manageme: 4.8% (+70.3%)
- State Street Corpora: 4.5% (-0.7%)
- Vulcan Value Partner: 3.4% (+13.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.4% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Forward P/E 6.0x attractive for 24% earnings growth. Balance sheet: strong liquidity (11.3x). Revenue declining -7% YoY, concerning. Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.9B |
| Beta | 0.37 |
| 52W Range | $302.44 - $373.23 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -50.00 |
| Forward P/E | 6.0 |
| Current P/E | 7.4 |
| YoY Growth | 24.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.4% to -1.0% (-5.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.0pp (needs >4.0% for momentum thesis). Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 51. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.04% (CS: 41) | Neutral |
| RSI_14 | 51.2 | Neutral |
| MACD Histogram | -0.21 | Bearish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 0.979x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $331.29
- **Stop Loss:** $318.57 (3.8% risk)
- **Target:** $344.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 78
- **Position Value:** $25,840.62
- **Portfolio %:** 25.84%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-02-02 (Est: $13.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $14.52 | $7.54 | -48.1% |
| 2025Q2 | $14.82 | $17.36 | +17.1% |
| 2025Q1 | $7.74 | $6.45 | -16.7% |
| 2024Q4 | $-17.42 | $-18.39 | -5.6% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*